Tyrphostin AG 825
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341204

CAS#: 149092-50-2

Description: Tyrphostin AG 825 is shown to be a potent inhibitor of EGFR (epidermal growth factor receptor) and Neu (HER-2) kinases.


Chemical Structure

img
Tyrphostin AG 825
CAS# 149092-50-2

Theoretical Analysis

MedKoo Cat#: 341204
Name: Tyrphostin AG 825
CAS#: 149092-50-2
Chemical Formula: C19H15N3O3S2
Exact Mass: 397.06
Molecular Weight: 397.467
Elemental Analysis: C, 57.42; H, 3.80; N, 10.57; O, 12.08; S, 16.13

Price and Availability

Size Price Availability Quantity
2mg USD 250
Bulk inquiry

Synonym: Tyrphostin AG 825; Tyrphostin AG-825; Tyrphostin AG825.

IUPAC/Chemical Name: 5-[(Benzothiazol-2-yl)thiomethyl]-4-hydroxy-3-methoxybenzylidenecyanoacetamide,

InChi Key: KXDONFLNGBQLTN-WUXMJOGZSA-N

InChi Code: InChI=1S/C19H15N3O3S2/c1-25-15-8-11(6-12(9-20)18(21)24)7-13(17(15)23)10-26-19-22-14-4-2-3-5-16(14)27-19/h2-8,23H,10H2,1H3,(H2,21,24)/b12-6+

SMILES Code: O=C(N)/C(C#N)=C/C1=CC(CSC2=NC3=CC=CC=C3S2)=C(O)C(OC)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 397.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Wolfson E, Solomon S, Schmukler E, Goldshmit Y, Pinkas-Kramarski R. Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer. Cell Death Dis. 2018 Jan 19;9(2):47. doi: 10.1038/s41419-017-0067-7. PubMed PMID: 29352243; PubMed Central PMCID: PMC5833446.

2: Wu L, Ramirez SH, Andrews AM, Leung W, Itoh K, Wu J, Arai K, Lo EH, Lok J. Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability. J Neurochem. 2016 Jan;136(2):250-7. doi: 10.1111/jnc.13374. Epub 2015 Nov 10. PubMed PMID: 26438054; PubMed Central PMCID: PMC4959605.

3: Bodiga VL, Thokala S, Vemuri PK, Bodiga S. Zinc pyrithione inhibits caspase-3 activity, promotes ErbB1-ErbB2 heterodimerization and suppresses ErbB2 downregulation in cardiomyocytes subjected to ischemia/reperfusion. J Inorg Biochem. 2015 Dec;153:49-59. doi: 10.1016/j.jinorgbio.2015.09.010. Epub 2015 Sep 26. PubMed PMID: 26436560.

4: Brechbuhl HM, Li B, Smith RW, Reynolds SD. Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2014 Nov 15;307(10):L800-10. doi: 10.1152/ajplung.00201.2014. Epub 2014 Sep 12. PubMed PMID: 25217659; PubMed Central PMCID: PMC4233294.

5: Cheng JC, Qiu X, Chang HM, Leung PC. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells. Biochem Biophys Res Commun. 2013 Apr 26;434(1):81-6. doi: 10.1016/j.bbrc.2013.03.062. Epub 2013 Mar 29. PubMed PMID: 23542467.

6: Matsukawa R, Hirooka Y, Ito K, Sunagawa K. Inhibition of neuregulin-1/ErbB signaling in the rostral ventrolateral medulla leads to hypertension through reduced nitric oxide synthesis. Am J Hypertens. 2013 Jan;26(1):51-7. doi: 10.1093/ajh/hps005. Epub 2012 Dec 13. PubMed PMID: 23382327.

7: Ashton JM, Balys M, Neering SJ, Hassane DC, Cowley G, Root DE, Miller PG, Ebert BL, McMurray HR, Land H, Jordan CT. Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell. 2012 Sep 7;11(3):359-72. doi: 10.1016/j.stem.2012.05.024. Epub 2012 Aug 2. PubMed PMID: 22863534; PubMed Central PMCID: PMC4023631.

8: Ahmad ZK, Brown CM, Cueva RA, Ryan AF, Doherty JK. ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas. Otol Neurotol. 2011 Jul;32(5):841-7. doi: 10.1097/MAO.0b013e31821f7d88. PubMed PMID: 21659924; PubMed Central PMCID: PMC3584631.

9: Hsu FN, Yang MS, Lin E, Tseng CF, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011 May;300(5):E902-8. doi: 10.1152/ajpendo.00610.2010. Epub 2011 Mar 1. PubMed PMID: 21364123.

10: Treekitkarnmongkol W, Suthiphongchai T. High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K. World J Gastroenterol. 2010 Aug 28;16(32):4047-54. PubMed PMID: 20731018; PubMed Central PMCID: PMC2928458.

11: Feng PH, Hsiung TC, Kuo HP, Huang CD. Cross-talk between bradykinin and epidermal growth factor in regulating IL-6 production in human airway smooth muscle cells. Chang Gung Med J. 2010 Jan-Feb;33(1):92-9. PubMed PMID: 20184800.

12: Levchenko V, Zheleznova NN, Pavlov TS, Vandewalle A, Wilson PD, Staruschenko A. EGF and its related growth factors mediate sodium transport in mpkCCDc14 cells via ErbB2 (neu/HER-2) receptor. J Cell Physiol. 2010 Apr;223(1):252-9. doi: 10.1002/jcp.22033. PubMed PMID: 20049896.

13: Koval J, Mikes J, Jendzelovský R, Kello M, Solár P, Fedorocko P. Degradation of HER2 receptor through hypericin-mediated photodynamic therapy. Photochem Photobiol. 2010 Jan-Feb;86(1):200-5. doi: 10.1111/j.1751-1097.2009.00639.x. Epub 2009 Nov 12. PubMed PMID: 19912559.

14: Luo B, Yu S, Zhuang L, Xia S, Zhao Z, Rong L. Induction of ERBB2 nuclear transport after radiation in breast cancer cells. J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):350-3. doi: 10.1007/s11596-009-0317-8. Epub 2009 Jun 10. PubMed PMID: 19513620.

15: Zhang L, Davis JS, Zelivianski S, Lin FF, Schutte R, Davis TL, Hauke R, Batra SK, Lin MF. Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. Cancer Lett. 2009 Nov 18;285(1):58-65. doi: 10.1016/j.canlet.2009.04.041. Epub 2009 May 24. PubMed PMID: 19467571; PubMed Central PMCID: PMC2780578.

16: Kedrin D, Wyckoff J, Boimel PJ, Coniglio SJ, Hynes NE, Arteaga CL, Segall JE. ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation. Clin Cancer Res. 2009 Jun 1;15(11):3733-9. doi: 10.1158/1078-0432.CCR-08-2163. Epub 2009 May 19. PubMed PMID: 19458057; PubMed Central PMCID: PMC2859965.

17: Stanya KJ, Liu Y, Means AR, Kao HY. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. J Cell Biol. 2008 Oct 6;183(1):49-61. doi: 10.1083/jcb.200806172. PubMed PMID: 18838553; PubMed Central PMCID: PMC2557042.

18: Son MY, Kim J, Han HW, Woo SM, Cho YS, Kang YK, Han YM. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells. Reproduction. 2008 Oct;136(4):423-32. doi: 10.1530/REP-08-0080. Epub 2008 Jun 26. PubMed PMID: 18583472.

19: Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song CZ, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D'Amour KA, Chesnut JD, Rao MS, Blau CA, Robins AJ. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood. 2007 Dec 1;110(12):4111-9. Epub 2007 Aug 29. PubMed PMID: 17761519; PubMed Central PMCID: PMC2190616.

20: Trinh NT, Privé A, Kheir L, Bourret JC, Hijazi T, Amraei MG, Noël J, Brochiero E. Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes. Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L870-82. Epub 2007 Jul 13. PubMed PMID: 17631610.